Prevtec microbia
Date | Investors | Amount | Round |
---|---|---|---|
€3.0m | Early VC | ||
N/A | $4.7m | Early VC | |
$2.5m | Early VC | ||
N/A | $8.0m | Debt | |
$59.9m Valuation: $60.0m | Acquisition | ||
Total Funding | $10.5m |
Related Content
Recent News about Prevtec microbia
EditPrevtec Microbia specializes in developing and commercializing innovative microbial solutions aimed at improving animal health and productivity. Operating in the animal health industry, the company primarily serves livestock producers and veterinary professionals. Prevtec Microbia's core product offerings include probiotics and other microbial-based products designed to enhance the gut health of animals, thereby improving their overall well-being and productivity. The company operates on a B2B (business-to-business) model, generating revenue through the sale of its microbial solutions to farms, veterinary clinics, and animal health distributors. By focusing on cutting-edge research and development, Prevtec Microbia aims to address key challenges in animal health, such as disease prevention and growth promotion, while reducing the need for antibiotics. The company is headquartered in Basel, Switzerland, and leverages a global network to distribute its products.
Keywords: microbial solutions, animal health, probiotics, livestock, veterinary, gut health, productivity, B2B, disease prevention, antibiotic reduction.